tbuckley/cabot-search huggingface dataset:
THE JOURNAL OF THE AMEICAN MEDICAL ASSOCIATION
Journal: JAMA (1913)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Thyroid scintigram. Sensitivity with sodium pertechnetate Tc 99m and gamma camera with pinhole collimator
Authors: U. Y. Ryo
Journal: JAMA (1976)

To evaluate the reliability of thyroid scintigraphy in the diagnosis of nodular growths, scintigrams of patients who later underwent thyroidectomy were reviewed and correlated with pathologic findings. The scintigrams were all obtained with a 5-mm single-hole collimator-equipped gamma-scintillation camera after intravenous injection of 5 millicuries of sodium pertechnetate Tc 99m. In the group of 92 patients, six of whom had two histologically different lesions, 149 nodules were identified pathologically. There were 26 nodules 2 to 5 mm in diameter, of which 22 were benign and four were malignant. None of the 22 benign nodules were delineated scintigraphically. Superior image quality and resolution, low radiation dose, technical simplicity, and speed make Tc pinhole-camera scintigraphy the best procedure available for routine thyroid imaging. (<i>JAMA</i>235:1235-1238, 1976)
THE SURGERY OF THE BILIARY APPARATUS.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1–59
Journal: Kidney International Supplements (2017)

[This corrects the article DOI: 10.1016/j.kisu.2017.04.001.].
Plasma Thymus and Activation-Regulated Chemokine (TARC) As Diagnostic Marker in Pediatric Hodgkin Lymphoma
Authors: Eline Zijtregtop, Waichu Wong, Friederike Meyer- Wentrup, Martha Lopez-Yurda, Raoull Hoogendijk, Patty Kok, Michel Zwaan, Auke Beishuizen
Journal: Blood (2018)
Imported Dengue—United States, 1991
Journal: JAMA (1992)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Comparison of interstudy reproducibility of cardiovascular magnetic resonance and 2D-echocardiography in a mixed study group and implications for clinical trial planning Frank Grothues, Gillian S. Smith, Nick G. Bellenger, Peter Collins, Helmut U. Klein, Dudley J. Pennell. Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, United Kingdom, Division of Cardiology, Otto-von-Guericke University, Magdeburg, Germany
Journal: Journal of the American College of Cardiology (2001)
PROPHYLAXIS OF SYPHILIS WITH ARSPHENAMIN
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Selective Retention of Hydroxylated PCB Metabolites in Blood
Authors: Ake Bergman, Eva Klasson-Wehler, Hiroaki Kuroki
Journal: Environmental Health Perspectives (1994)

Polychlorinated biphenyls (PCBs) are important environmental contaminants, and their toxicity to wildlife and humans are of major concern. PCBs form persistent and abundant metabolites, PCB methyl sulfones, that accumulate in biota. We now report that certain hydroxylated PCB metabolites show a strong and selective accumulation in mammalian blood. Plasma from experimentally PCB-dosed rats and blood from environmentally exposed grey seals (Halichoerus grypus) and humans were analyzed. Among all possible hydroxylated metabolites of PCB that may be formed, only a few, dominated by 4-OH-2,3,5,3',4'-pentachlorobiphenyl and 4-OH-2,3,5,6,2',4',5'-heptachlorobiphenyl, were found in the blood samples. All identified compounds have a structure with the hydroxy group in a para or meta position, with chlorine atoms on vicinal carbon atoms. The concentrations of hydroxylated PCB in the blood were almost in the same range as the most persistent PCB congeners both for seals and humans.
Impaired ability of neutrophils to produce oxygen-derived free radicals in patients with chronic liver disease and hepatocellular carcinoma
Authors: M Uehara
Journal: Hepatology (1994)

To evaluate whether neutrophil bactericidal function, the ability to produce oxygen-derived free radicals, is altered in patients with chronic liver disease, we measured chemiluminescence amplified by a luciferin analog (Cypridina luciferin analog-dependent chemiluminescence) and luminol (luminol-dependent chemiluminescence) in response to N-formyl-Met-Lue-Phe by neutrophils from patients with chronic liver diseases due to C and/or B type hepatitis: chronic active hepatitis, cirrhosis and hepatocellular carcinoma. Both Cypridina luciferin analog-dependent chemiluminescence and luminol-dependent chemiluminescence were significantly decreased in neutrophils from patients with chronic liver disease (hepatocellular carcinoma<cirrhosis<chronic active hepatitis) when they were compared with normal healthy subjects. The reduction of Cypridina luciferin analog-dependent chemiluminescence in chronic active hepatitis and cirrhosis was more sensitive than Cypridina luciferin analog-dependent chemiluminescence; however, in hepatocellular carcinoma, luminol-dependent chemiluminescence was more reduced than luminol-dependent chemiluminescence. Although there were not significant correlations between glutamic pyruvic transaminase and Cypridina luciferin analog-dependent chemiluminescence/luminol-dependent chemilumiluminescence. there were significant negative correlations between total billirubin and Cypridina luciferin analog-dependent chemiluminescence/luminol-dependent chemiluminescence/luminol-dependent chemiluminescence. Furthermore, there were significant positive correlations between albumin/prothrombin time and Cypridina luciferin analog-dependent chemiluminescence/luminol-dependent chemiluminescence. These data suggest that an impaired ability to produce oxygen-derived free radicals may contribute to the susceptibility to infection in patients with chronic liver disease. (Hepatology 1994;20:326–330.)
Sterility in the Woman and its Treatment.
Journal: JAMA (1893)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for malignant peritoneal mesothelioma (MPM)
Authors: M. E. Hesdorffer, M. L. Keohan, J. A. Chabot, S. Talbot, K. S. Fountain, M. Gabay, S. Lee, R. N. Taub
Journal: Journal of Clinical Oncology (2005)

7305 Background: We have carried out a prospective single-institution Phase I-II trial of surgical debulking, intraperitoneal chemotherapy and immunotherapy followed by whole abdominal radiotherapy in patients with malignant peritoneal mesothelioma. (MPM). Methods: Between 1997 and 2000 27 patients with malignant peritoneal mesothelioma were enrolled, 23 with the epithelial subtype, and 4 with a sarcomatoid or mixed subtype. The treatment regimen consisted of: initial exploratory laparotomy with surgical debulking and placement of indwelling intraperitoneal (ip) catheters; four ip courses of doxorubicin alternating with four ip courses of cisplatin; 4 ip doses of gamma interferon; a second laparotomy with biopsy verification of complete response or attempted resection of residual disease; intraoperative hyperthermic (41 degrees centigrade) ip perfusion with mitomycin plus cisplatin; and finally whole abdominal radiotherapy. Results: The median overall survival was 68 months with a 3 year survival of 67% (95% CI: 46–81%). Thirteen patients died from their disease at a mean of 37.2 (range 8–68) months after initiation of treatment. Ten patients are alive with a laparotomy-verified complete pathologic response and without further evidence of disease at a mean of 58.5 (range 39–78) months. Four patients are alive with disease at a mean of 62 (range 54–81) months. The entire regimen was well tolerated; there were no patients with Grade III or IV hematological toxicities, 2 patients with Grade III ototoxicity, and 3 patients with Grade III gastrointestinal toxicity. Conclusions: Based on the results of this study intensive multimodality therapy appears feasible and effective in this group of MPM patients. No significant financial relationships to disclose.
FDA issues pediatric respiratory device alert
Authors: M. F. Goldsmith
Journal: JAMA (1983)

An attempt to facilitate life in critically ill newborns and small infants can lead to death if the components of the respiratory assistance devices used are not compatible, warned the Food and Drug Administration's National Center for Devices and Radiological Health (NCDRH) recently. In an alert letter sent to all US hospitals, NCDRH Office of Health Affairs director Marlene E. Haffner, MD, warned that this hazard can occur if certain breathing system connectors and adapters intended to reduce deadspace are used together. Ideally, there should be a slight gap between the lumen of the tracheal tube connector and that of the fresh gas (oxygen) inlet tube to serve as an exhalation pathway. If mismatched—that is, abutting—adapters and connectors are used during anesthesia or respiratory therapy, obliteration of this gap could either produce high resistance to exhalation or prevent it completely, thereby increasing intrapulmonary pressure and almost certainly causing pneumothorax. The
THE INSPECTION OF MERCHANTABLE WATERS.
Journal: JAMA (1893)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Linezolid: The First Oxazolidinone Antimicrobial
Authors: D. A. Lindley
Journal: Annals of Internal Medicine (2003)

Letters18 November 2003Linezolid: The First Oxazolidinone AntimicrobialD. A. Lindley, MDD. A. Lindley, MDFrom Little Rock, AR 72205.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-139-10-200311180-00016 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:By reading Moellering's review on linezolid, I learned several new things about this useful drug (1). I was taken aback, however, by the author's comment that it is relatively expensive. While I have no first-hand knowledge of antibiotic costs in Boston, I can say that in Little Rock, Arkansas, where I have a private infectious diseases practice, the daily cost of the drug is 10 to 100 times higher than that of almost any other oral antibiotic I prescribe (the also-exorbitant antifungal agents are the next closest). It is essentially unaffordable for outpatient use by the majority ...Reference1. Moellering RC. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med. 2003;138:135-42. [PMID: 12529096] LinkGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Little Rock, AR 72205. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoLinezolid: The First Oxazolidinone Antimicrobial Robert C. Moellering Jr. Linezolid: The First Oxazolidinone Antimicrobial David L. Paterson , A. William Pasculle , and Kenneth McCurry Linezolid: The First Oxazolidinone Antimicrobial Robert C. Moellering Jr. Linezolid: The First Oxazolidinone Antimicrobial James R. Johnson Metrics 18 November 2003Volume 139, Issue 10Page: 863KeywordsAntifungalsAntimicrobialsDrugsInfectious diseasesOutpatients ePublished: 18 November 2003 Issue Published: 18 November 2003 Copyright & PermissionsCopyright © 2003 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Laparoscopic Therapy of Cholelithiasis
Authors: J. Ponsky
Journal: Annual Review of Medicine (1993)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), emerged in China in December 2019 and quickly spread around the globe, killing more than 4 million people and causing a severe economic crisis. ...Read More
II. Comments
Authors: Chauncey D. Leake
Journal: JAMA (1965)

The development of the Institute for Biomedical Research represents a return to the purposes, it seems to me, that were so clearly expressed in the founding of the American Medical Association in 1847—to improve the standards of medical training and of medical practice. We realize now as the founders did then that those standards are dependent upon verifiable information about ourselves and our environment. That leads me to make a philosophical comment about Dr. Page, who is a pragmatist. He represents the best in skeptical scientific advance in biomedical affairs, recognizing always that the verifiable truth we may learn about ourselves and our environment is always tentative, always subject to revision, and ever to be approached in the spirit expressed by Professor Conklin many years ago: "Unwelcome truth is better than cherished error." It is the self-critical, self-corrective approach which has always been so characteristic of the medical advance that
No green light for grass in glaucoma
Authors: E. R. Gonzalez
Journal: JAMA (1980)

What's new in the area of marijuana treatment for glaucoma? Not much, said Keith Green, PhD, Regents Professor of Ophthalmology, Medical College of Georgia, Augusta, in an interview with<i>JAMA</i>MEDICAL NEWS. Green is engaged in an ongoing effort to screen the naturally occurring and synthetic cannabinoids, as well as the water-soluble molecular components of the marijuana plant, for their intraocular pressure-lowering effects by testing them in rabbits. (There is no good animal model for glaucoma, and even these rabbits have normal intraocular pressure.) But so far, Green says, "It looks as if we can't have the pressure fall without the euphoriant effect." Essentially, then, a patient who wishes to use a cannabinoid to control his intraocular pressure satisfactorily must stay "stoned" all day. Other undesirable side effects of the cannabinoids include tachycardia, conjunctival hyperemia, respiratory and reproductive changes, and visual problems (for example, difficulties with color vision and dark
SNOMED International (systematized nomenclature of human and veterinary medicine). 3rd ed. Edited by R.A. Cote, D.J. Rothwell, J.L. Palotay and R.S. Beckett. Vol. I (868 pp) and Vol. II (1160 pp), Numeric indices, Vol. III (1,004 pp) and Vol. IV (1,260 pp), Alphabetical Indices. Chicago: College of American Pathologists, 1993. $300 ($225 for members of College of American Pathologists)
Authors: J Ludwig
Journal: Hepatology (1994)
Capacity of Persons With Mental Retardation to Consent to Participate in Randomized Clinical Trials
Authors: Celia Fisher
Journal: American Journal of Psychiatry (2006)

Objective: Adults with mental retardation have histories of cognitive and adaptive deficits posing unique ethical challenges for research consent assessment. This study examined the capacity of persons with mental retardation to consent to participate in randomized clinical trials. Method: A total of 150 adults (50 each with mild and moderate mental retardation and 50 comparison subjects without mental retardation) responded to a set of consent questions for a hypothetical randomized clinical trial testing a medication for aggressive disorders. Intelligence, adaptive behavior, medical treatment history, and consent history were evaluated. Univariate and multivariate methods were used to compare performance across and within groups. Results: Comparison subjects scored significantly higher on measures of consent capacity than participants with mild mental retardation, who scored higher than those with moderate mental retardation. Most subjects with mental retardation were able to make a participation choice, and many understood research methods and appreciated the protagonist’s disorder and the consequences of participation. Almost half of those with mild mental retardation understood human subject protections. Performance was weakest on understanding the purpose of research and reasoning about whether to participate, suggesting vulnerability to the therapeutic misconception. Psychiatric and experiential factors did not predict consent capacity. Conclusions: While adults with mental retardation as a group showed consent deficits, many attained consent capacity scores comparable to those of comparison subjects. Investigators should consider individual differences and a consent format suited to deficits in language, memory, and attention before restricting consent opportunities for persons with mental retardation.
CASES IN MIDWIFERY
Authors: T. Radford
Journal: BMJ (1856)

I was desired by Mrs. Blakeley to visit a hospital patient residing in Shude- bill, who was flooding.I found her in labour of her sixth child.The pains were strong and forcing; and the hie- morrhage, which had existed only slightly for several hours, had now become very profuse.She was pale, and her pulse was frequent and feeble.The os uteri was di- lated rather more than the size of a crown-piece; it was soft and dilatable.The placenta (which must have been centrally fixed here) was felt occupying, and, as it were, protruding through the uterine orifice.The head of the child was felt above.The flow of blood was at this time very alarming.Having had a bandage and compress applied, I passed my hand, and, as quickly as possible, completely detacked the placenta, and afterwards ruptured the membranes.The bleeding immediately ceased.The pains continued very effective, so that the head rapidly descended, pushing